User profiles for D. S. Miller
David Scott MillerUniversity of Texas Southwestern Medical Center Verified email at UTSouthwestern.edu Cited by 12927 |
The ecological and evolutionary consequences of systemic racism in urban environments
BACKGROUND Human activity and decisions drive all life in cities. Worldwide, cities are
characterized by extensive anthropogenic transformation of the landscape, modification of …
characterized by extensive anthropogenic transformation of the landscape, modification of …
The outdoor air pollution and brain health workshop
…, MT Kleinman, A Kirshner, C Lawler, DS Miller… - Neurotoxicology, 2012 - Elsevier
Accumulating evidence suggests that outdoor air pollution may have a significant impact on
central nervous system (CNS) health and disease. To address this issue, the National …
central nervous system (CNS) health and disease. To address this issue, the National …
Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy
Pharmacotherapy of central nervous system (CNS) disorders (eg, neurodegenerative
diseases, epilepsy, brain cancer, and neuro-AIDS) is limited by the blood-brain barrier. P-…
diseases, epilepsy, brain cancer, and neuro-AIDS) is limited by the blood-brain barrier. P-…
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease
W Zhang, T Wang, Z Pei, DS Miller, X Wu… - The FASEB …, 2005 - Wiley Online Library
A growing body of evidence indicates that an inflammatory process in the substantia nigra,
characterized by activation of resident microglia, likely either initiates or aggravates nigral …
characterized by activation of resident microglia, likely either initiates or aggravates nigral …
[HTML][HTML] Lenvatinib plus pembrolizumab for advanced endometrial cancer
…, AD Santin, E Colomba, DS Miller… - … England Journal of …, 2022 - Mass Medical Soc
Background Standard therapy for advanced endometrial cancer after failure of platinum-based
chemotherapy remains unclear. Methods In this phase 3 trial, we randomly assigned, in a …
chemotherapy remains unclear. Methods In this phase 3 trial, we randomly assigned, in a …
The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer
LAG Ries, PA Wingo, DS Miller, HL Howe, HK Weir… - Cancer, 2000 - Wiley Online Library
BACKGROUND This annual report to the nation addresses progress in cancer prevention
and control in the US with a special section on colorectal cancer. This report is the joint effort …
and control in the US with a special section on colorectal cancer. This report is the joint effort …
Neuropsychiatric symptoms in Alzheimer's disease
…, J Amatniek, J Cedarbaum, R Brashear, DS Miller - Alzheimer's & …, 2011 - Elsevier
Neuropsychiatric symptoms (NPS) are core features of Alzheimer’s disease and related
dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms …
dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms …
Soluble CD14 participates in the response of cells to lipopolysaccharide.
EA Frey, DS Miller, TG Jahr, A Sundan… - The Journal of …, 1992 - rupress.org
CD14 is a 55-kD protein found both as a glycosylphosphatidyl inositol-linked protein on the
surface of mononuclear phagocytes and as a soluble protein in the blood. CD14 on the cell …
surface of mononuclear phagocytes and as a soluble protein in the blood. CD14 on the cell …
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
…, HS Lichenstein, MM Wurfel, DS Miller… - The Journal of …, 1994 - rupress.org
CD14 is a 55-kD protein found as a glycosylphosphatidylinositol (GPI)-anchored protein on
the surface of monocytes, macrophages, and polymorphonuclear leukocytes, and as a …
the surface of monocytes, macrophages, and polymorphonuclear leukocytes, and as a …
[PDF][PDF] Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study
…, DS McMeekin, J Sorosky, DS Miller… - Journal of clinical …, 2005 - academia.edu
… Miller, GlaxoSmithKline. For a detailed description of these categories, or for more information
about ASCO’s conflict of interest policy, please refer to the Author Disclosure Declaration …
about ASCO’s conflict of interest policy, please refer to the Author Disclosure Declaration …